Design and development of liposomes for colon targeted drug delivery

Journal of Drug Targeting

Volumn 21, Issue 2, 2013, Pages 146-160

  Gupta, Anand S ^a   Kshirsagar, Sanjay J ^a   Bhalekar, Mangesh R ^b   Saldanha, Tina ^a  

^a AISSMS COLLEGE OF PHARMACY   (India)

^b Department of Pharmaceutics ^*  (United States)

Author keywords

Budesonide; Myeloperoxidase; Optimization; Site specific; Ulcerative colitis

Indexed keywords

ACETIC ACID; BUDESONIDE; CHOLESTEROL; EUDRAGIT; LIPOSOME; MYELOPEROXIDASE; PHOSPHATIDYLCHOLINE; STEARIC ACID; SURFACTANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CHEMICAL COMPOSITION; COLITIS; COLON; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG CAPSULE; DRUG DOSAGE FORM COMPARISON; DRUG SAFETY; DRUG STABILITY; ENZYME ACTIVITY; EX VIVO STUDY; FILM; FREEZE DRYING; HISTOPATHOLOGY; HYDRATION; IN VIVO STUDY; LIPID VESICLE; LIPOSOMAL DELIVERY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; RESPONSE SURFACE METHOD; SCANNING ELECTRON MICROSCOPY; SOLID STATE; ZETA POTENTIAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CALORIMETRY, DIFFERENTIAL SCANNING; COLON; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DESIGN; DRUG STABILITY; INFLAMMATORY BOWEL DISEASES; LIPOSOMES; MALE; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; PEROXIDASE; RATS; RATS, WISTAR; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SURFACE PROPERTIES;

EID: 84873326942     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.734311     Document Type: Article

References (35)

1. Akhgari A, Afrasiabi Garekani H, Sadeghi F, Azimaie M. (2005). Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm, 305, 22-30. (Pubitemid 41562214)
2. Asghar LF, Chandran S. (2006). Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Pharm Sci, 9, 327-338. (Pubitemid 46614339)
3. Bradley PP, Priebat DA, Christensen RD, Rothstein G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol, 78, 206-209. (Pubitemid 12171880)
4. Camuesco D, Gálvez J, Nieto A, Comalada M, Rodríguez- Cabezas ME, Concha A, Xaus J, Zarzuelo A. (2005). Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr, 135, 687-694. (Pubitemid 40464089)
5. Chaud MV, Tamascia P, De Lima AC, Paganelli MO, Gremião MPD, De Freitas O. (2010). Solid dispersions with hydrogenated castor oil increase solubility, dissolution rate and intestinal absorption of praziquantel. Braz J Pharm Sci, 46, 473-481.
6. Gupta VK, Beckert TE, Price JC. (2001). A novel pH-and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm, 213, 83-91. (Pubitemid 32119464)
7. Hajj Hussein IA, Tohme R, Barada K, Mostafa MH, Freund JN, Jurjus RA, Karam W, Jurjus A. (2008). Inflammatory bowel disease in rats: bacterial and chemical interaction. World J Gastroenterol, 14, 4028-4039.
8. http://MedicineNet.Com. Accessed on 4 September 2011.
9. Ibekwe VC, Kendall RA, Basit AW. (2004). Drug delivery to the colon. The drug delivery companies report spring/summer, 27-30.
10. Jubeh TT, Barenholz Y, Rubinstein A. (2004). Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm Res, 21, 447-453. (Pubitemid 38338980)
11. Karki R, Subramanya G, Udupa N. (2009). Formulation and evaluation of coencapsulated rifampicin and isoniazid liposomes using different lipids. Acta Pharmaceutica Sciencia, 51, 177-188.
12. Kirby C, Clarke J, Gregoriadis G. (1980). Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. Biochem J, 186, 591-598.
13. Kogure K, Nakamura C, Okuda O, Hayashi K, Ueno M. (1997). Effect of dicetylphosphate or stearic acid on spontaneous transfer of protein from influenza virus-infected cells to dimyristoylphosphatidylcholine liposomes. Biochim Biophys Acta, 1329, 174-182. (Pubitemid 27464812)
14. Kumar M, Pathak K, Misra A. (2009). Formulation and characterization of nanoemulsion-based drug delivery system of risperidone. Drug Dev Ind Pharm, 35, 387-395.
15. Lee HL, Mukherjee SK. (2006). Drug delivery-oral colon-specific. Encyclopedia of Pharmaceutical Technology. In: James S, ed. NY: Informa Health Care, 871-885.
16. Lee S, Lee J, Choi YW. (2007). Characterization and evaluation of freezedried liposomes loaded with ascorbyl palmitate enabling antiaging therapy of the skin. Bull Korean Chem Soc, 28, 99-102. (Pubitemid 46168782)
17. Lu D, Hickey AJ. (2005). Liposomal dry powders as aerosols for pulmonary delivery of proteins. AAPS PharmSciTech, 6, E641-E648. (Pubitemid 43046101)
18. Marsanasco M, Marquez AI, Wagner OR, Alonso SD, Chiaramoni NS. (2011). Liposomes as vehicles for vitamins E and C: an alternative to fortify orange juice and offer vitamin C protection after heat treatment. Food Res Int, 44, 3039-3046.
19. Med DX, Alani AB, Robinson JR. (2005). Extended-release and targeted drug delivery systems. Remington-The Science and Practice of Pharmacy. New Delhi: B. I. Publications Pvt. Ltd., 939-963.
20. Misra A, Shah SP. (2004). Liposomal amikacin dry powder inhaler: effect of fines on in vitro performance. AAPS PharmSciTech, 5, Article 65.
21. Naikwade S, Bajaj A. (2009). Preparation and in vitro evaluation of budesonide spray dried microparticles for pulmonary delivery. Sci Pharm, 77, 419-441.
22. Nounou MM, El-Khordagui LA, Khalafallah NA, Khalil SA. (2006). In vitro release of hydrophilic and hydrophobic drugs from liposomal dispersions and gels. Acta Pharm, 56, 311-324. (Pubitemid 44422511)
23. Philip AK, Philip B. (2010). Colon targeted drug delivery systems: a review on primary and novel approaches. Oman Med J, 25, 79-87.
24. Riaz M. (1996). Liposomes preparation methods. Pak J Pharm Sci, 9, 65-77.
25. Sawant KK, Varia JK, Dodiya SS. (2008). Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization. Current Drug Deliv Rev, 5, 64-69. (Pubitemid 351225636)
26. Sener G, Aksoy H, Sehirli O, Yüksel M, Aral C, Gedik N, Cetinel S, Yegen BC. (2007). Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Dig Dis Sci, 52, 2122-2132. (Pubitemid 47246535)
27. Shaikh K, Pawar A. (2010). Liposomal delivery enhances cutaneous availability. Lat Am J Pharm, 29, 763-770.
28. Singh UP, Singh NP, Singh B, Hofseth LJ, Price RL, Nagarkatti M, Nagarkatti PS. (2009). Resveratrol (trans-3,5,4́-trihydroxystilbene) induces SIRT1 and down-regulates NF-κB activation to abrogate DSS-induced colitis. J Pharmacol Exp Ther (In Press). DOI: 10.1124/jpet.109.160838.
29. Subrahmanyam CVS. (2000). Textbook of Physical Pharmaceutics. New Delhi, India: Vallabh Prakashan.
30. Varshosaz J, Emami J, Tavakoli N, Minaiyan M, Rahmani N, Dorkoosh F, Mahzouni P. (2011). Development of novel budesonide pellets based on CODES™ technology: in vitro/in vivo evaluation in induced colitis in rats. Daru, 19, 107-117.
31. Vijayan V. (2010). Preparation and characterization of anti diabetic drug loaded solid lipid nanoparticles. JITPS, 1, 320-328.
32. Yang L. (2008). Biorelevant dissolution testing of colon-specific delivery systems activated by colonic microflora. J Control Release, 125, 77-86. (Pubitemid 350299614)
33. Yao J, Wang JY, Liu L, Zeng WS, Li YX, Xun AY, Zhao L, Jia CH, Feng JL, Wei XX, Wang LS. (2011). Polydatin ameliorates DSS-induced colitis in mice through inhibition of nuclear factor-κB activation. Planta Med, 77, 421-427.
34. Zhang P, Tu Y, Wang S, Wang Y, Xie Y, Li M, Jin Y. (2011). Preparation and characterization of budesonide loaded solid lipid nanoparticles for pulmonary delivery. J Chinese Pharm Sci, 1003-1057, 4-390-07, 390-396.
35. Zhang X, Liu J, Qiao H. (2010). Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Tech, 197, 120-128.